GAPDH and neoplasm: 1,2,3,4,6‐penta‐O‐galloyl‐β‐d‐glucopyranose has been reported to compete with NAD+ and inorganic phosphate (Pi) to impede GAPDH activity; however, its inhibitory efficacy in tumor models remains to be empirically validated168 (Table 2).